Treatment Deintensification Is Uncommon in Adults with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
McAlister FA, Youngson E, Eurich DT
Circ Cardiovasc Qual Outcomes 2017;10:e003514
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
McAlister FA, Youngson E, Eurich DT
Circ Cardiovasc Qual Outcomes 2017;10:e003514
Leggi
Evans CEL, Greenwood DC, Threapleton DE, et al.
Am J Clin Nutr. Pub online April 12, 2017
Leggi
Rawshani A, Rawshani A, Franzén S, et al.
N Engl J Med 2017;376:1407-18
Leggi
Ingelfinger JR, Jarcho JA
N Engl J Med 2017;376:1473-4
Leggi
Mayer-Davis EJ, Lawrence JM, Dabelea D, et al.
N Engl J Med 2017;376:1419-29
Leggi
van Zon SKR, Snieder H, Bültmann U, et al.
BMJ Open 2017;7:e015275
Leggi
Dean PG, Kukla A, Stegall MD, et al.
BMJ 2017;357:j1321
Leggi
Barr ELM, Cunningham J, Tatipata S, et al.
Diabetic Medicine. Pub. online April 4, 2017
Leggi
Ibanez‐Bruron MC, Solebo AL, Cumberland PM, et al., and The Diabetic Eye Disease in Childhood Study (DECS) group
Diabetic Medicine. Pub. online April 4, 2017
Leggi
Zinman B, Inzucchi SE, Lachin JM, et al., On behalf of the EMPA-REG OUTCOME Investigators (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients)
Stroke. Pub. online April 6, 2017
Leggi